Does Maitake (Grifola frondosa) work?

Read Off Label rates the evidence for Maitake (Grifola frondosa) as Weak and the benefit magnitude as low, producing an overall grade of C+ (5.3/10). D-fraction beta-glucan is the headline molecule and the basis of the immune-adjuvant story.

Is Maitake (Grifola frondosa) safe?

Maitake (Grifola frondosa) has a low risk profile in published human data. Legal status: OTC. This is not medical advice — see the disclaimer.

Rankings / Immune & Inflammation

Maitake (Grifola frondosa)

Immune & Inflammation · Medicinal mushroom / beta-glucan

Tier C+

Reviewed by Read Off Label · Last reviewed Jun 8, 2026 · How we grade

beta-glucanotc

5.3 / 10

Tier C+

Ev 3 Bn 2 Sf 9

Bottom line

Read Off Label grades Maitake (Grifola frondosa) as C+ (5.3/10) based on weak evidence, low benefit magnitude, and a low-risk safety profile.

D-fraction beta-glucan is the headline molecule and the basis of the immune-adjuvant story.

Typical use: 500-3000 mg/day fruiting body extract; D-fraction-standardized products available — OTC.

What this is

D-fraction beta-glucan is the headline molecule and the basis of the immune-adjuvant story. Glycemic effect is small but real. Mostly small-trial Japanese literature; Western RCT replication is thin. Standardization to D-fraction or alpha-glucan content matters more than total mushroom weight.

Mechanism

D-fraction beta-glucan (1,6-branched 1,3-glucan); Dectin-1 activation; macrophage and NK cell stimulation; modest insulin-sensitizing effect via SX-fraction (alpha-glucan)

Dose & route

500-3000 mg/day fruiting body extract; D-fraction-standardized products available

Citations

Links go to the source. If a link is dead or you want something re-checked, let me know.

Common questions

Does Maitake (Grifola frondosa) work?: Read Off Label rates the evidence for Maitake (Grifola frondosa) as Weak and the benefit magnitude as low, producing an overall grade of C+ (5.3/10). D-fraction beta-glucan is the headline molecule and the basis of the immune-adjuvant story.
Is Maitake (Grifola frondosa) safe?: Maitake (Grifola frondosa) has a low risk profile in published human data. Legal status: OTC. This is not medical advice — see the disclaimer.
What is the typical dose for Maitake (Grifola frondosa)?: 500-3000 mg/day fruiting body extract; D-fraction-standardized products available
How does Maitake (Grifola frondosa) work?: D-fraction beta-glucan (1,6-branched 1,3-glucan); Dectin-1 activation; macrophage and NK cell stimulation; modest insulin-sensitizing effect via SX-fraction (alpha-glucan)

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.